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Enzyme-linked aptamer assay (ELAA)Many cases of inﬂuenza are reported worldwide every year. The inﬂuenza virus often acquires new anti-
genicity, which is known as antigenic shift; this results in the emergence of new virus strains, for which
preexisting immunity is not found in the population resulting in inﬂuenza pandemics. In the event a new
strain emerges, diagnostic tools must be developed rapidly to detect the novel inﬂuenza strain. The
generation of high afﬁnity antibodies is costly and takes time; therefore, an alternative detection system,
aptamer detection, provides a viable alternative to antibodies as a diagnostic tool. In this study, we
developed DNA aptamers that bind to HA1 proteins of multiple inﬂuenza A virus subtypes by the SELEX
procedure. To evaluate the binding properties of these aptamers using colorimetric methods, we devel-
oped a novel aptamer-based sandwich detection method employing our newly identiﬁed aptamers. This
novel sandwich enzyme-linked aptamer assay successfully detected the H5N1, H1N1, and H3N2 subtypes
of inﬂuenza A virus with almost equal sensitivities. These ﬁndings suggest that our aptamers are attrac-
tive candidates for use as simple and sensitive diagnostic tools that need sandwich system for detecting
the inﬂuenza A virus with broad subtype speciﬁcities.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Aptamers are artiﬁcial DNA or RNA segments that are designed
to bind a speciﬁc target [1,2]. Because of various advantages over
antibodies (e.g., capable of improving sensitivities by exponential
ampliﬁcation, lower production costs, relative ease of modiﬁcation,
tailored binding afﬁnity, and reversible denaturation), aptamers
are now thought to represent alternative options to antibodies
for diagnostics development [3–5]. In addition to the advantages
described above, aptamers are also possible to be linked with per-
oxidase-mimicking DNAzyme sequences [6].
Hemagglutinin (HA), which exists as trimeric spikes on the viral
membrane, plays a key role in the infection process of inﬂuenza
virus and is the major target for generating a of protective antibodyresponse [7,8]. The HA acquires antigenic variation, referred to as
antigenic shift or antigenic drift, resulting in a modiﬁed HA and/
or neuraminidase (NA) on the inﬂuenza viruses. This mechanism
interferes with effective immune responses, making it difﬁcult to
develop anti-inﬂuenza agents or diagnostic kits.
Various research groups have developed inﬂuenza aptamers
[9–12]. A22, developed by Joen et al., and A10, developed by Cheng
et al., can both block the binding of the virus to MDCK cells and
prevent viral infection [9,11]. The protective effect of A22 is com-
patible with infection by other types of human inﬂuenza viral
strains; however, the efﬁcacy was lower than that in the H3-type
inﬂuenza strain. Recently, subtype-speciﬁc RNA aptamers against
human inﬂuenza virus have been reported [10]. These aptamers
can distinguish between closely related H3N2 strains and may be
useful in the genotyping of H3N2 inﬂeunza viruses. Either way,
these aptamers described above showed relatively strict speciﬁcity
for the inﬂuenza virus. The binding ability of the aptamer to the
targets was found to be dependent on the tertiary structure of
the target [5].
In the current study, we developed DNA aptamers to detect var-
ious subtypes of inﬂuenza A viruses with high afﬁnity. After 10
rounds of SELEX procedures, aptamers that bound to recombinant
hemagglutinin (rHA) of H5N1, H1N1 and H3N2 of the inﬂuenza A
virus were isolated. Among them, three aptamers (RHA0006,
RHA0385, and RHA1635) were selected based on their binding
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binding properties against the inﬂuenza A virus, we developed a
sandwich enzyme linked aptamer assay (ELAA) involving
RHA0006 and RHA0385. This novel sandwich detection system
successfully detected the various subtypes of inﬂuenza A viral par-
ticles that were antigenically distinct. These ﬁndings suggest that
our novel aptamers are attractive candidates for use as rapid and
cost-effective diagnostic tools with broad subtype speciﬁcities.2. Materials and methods
2.1. Target protein and virus
His-tagged recombinant HA proteins that are expressed in
HEK293 cells were purchased from Sino Biological Inc. (Beijing,
PR China). His-tagged macrophage migration inhibitory factor
(His-MIF) was kindly provided by Dr. S. Tsuji (Kanagawa Research
Institute, Kanagawa, Japan) [12].
All experiments involving viruses were conducted at the IIT
Research Institute in accordance with institutional guidelines. Each
viral strain was grown in conﬂuent ﬂasks of MDCK cells. A/
Brisbane/59/07, A/California/04/09, and A/Singapore/16/86 stocks
were prepared at a multiplicity of infection (MOI) of 0.01 plaque-
forming unit (PFU)/cell. A/Brisbane/10/07, A/Wisconsin/67/05,
A/Moscow/10/99, A/Georgia/20/06, and Sindbis stocks were pre-
pared at an MOI of 0.05 PFU/cell. Virus stocks were prepared in
infection media (1 MEM + 3% NaHCO3, 1 MEM vitamin solu-
tion, 1  L-glutamine, 100 U/mL penicillin, 100 lg/mL streptomy-
cin, and 50 lg/mL gentamicin). After 1 h of infection, an overlay
of infection media supplemented with 2 lg/mL TPCK-treated tryp-
sin (Affymetrix/USB, Santa Clara, CA, USA) was added to each ﬂask.
When the cytopathic effect reached approximately 100%, the
supernatant was concentrated using Amicon Ultra centrifugal ﬁlter
devices with a 100,000 molecular weight cut-off (MWCO; Milli-
pore, Billerica, MA, USA) by centrifuging at 3000g at 4 C for
30 min. rg A/Japanese White Eye/Hong Kong/1038/06 was grown
in speciﬁc pathogen-free fertile eggs and harvested after 48 h;
the virus was diluted in 1  phosphate-buffered saline (PBS), pH
7.4, with 100 U/mL penicillin, 100 lg/mL streptomycin, and
50 lg/mL gentamicin. A titer was not available for this strain;
hence, 1:1000 and 1:100 dilutions of the stock were used to infect
the eggs. The semipuriﬁed virus was UV-inactivated, and the pro-
tein concentration was determined using the bicinchoninic assay
(BCA) (Pierce Biotechnology, Rockland, IL, USA).2.2. SELEX
DNA aptamers were selected using a previously described
method with some modiﬁcations [13]. The typical procedure has
been described below. TALON Superﬂow Metal Afﬁnity Resin
(20 lL; Takara Bio, Inc., Shiga, Japan) was mixed with 25 lg of
HA proteins (A/Anhui/1/05) in 200 lL of selection buffer
(SB; 50 mM Tris–HCl, pH 7.4, 100 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 0.01% Tween 20). The mixture was incubated for 30 min
at room temperature and then washed two times with SB. The ini-
tial ssDNA pools (2000 pmol) were denatured at 95 C for 5 min,
immediately cooled on ice for 5 min, and then pre-absorbed with
TALON resins in SB supplemented with tRNA and acetylated bovine
serum albumin (BSA; Wako Pure Chemical Industries, Osaka, Ja-
pan). Unbound ssDNA pools separated using an ultra-free MC col-
umn (Millipore) were mixed with 100 lL of HA-coated beads,
incubated for 30 min at room temperature, and then washed three
times with 750 lL of SB. Bound aptamer-HA1 complexes were
eluted with buffer containing 200 mM imidazole, separated using
an MC column, and collected by ethanol precipitation. The col-lected ssDNA samples were ampliﬁed by PCR (Ex Taq DNA Poly-
merase, Takara) with biotin-conjugated reverse primers in a total
volume of 400 lL. Ampliﬁed dsDNA was puriﬁed using NucleoSpin
Extract II (Takara), incubated with MyOne-SA beads (Invitrogen,
Carlsbad, CA, USA) in hybridization buffer (HB: 5 mM Tris–HCl,
pH 7.4, 1 mM EDTA, 2 M NaCl, 0.1% Tween 20), and then washed
two times in HB. For ssDNA preparation, bead-bound dsDNA was
eluted with 0.1 M NaOH, neutralized with 0.1 M HCl containing
0.1 M Tris–HCl, pH 7.4, and then puriﬁed using NucleoSpin Extract
II. We increased the selection pressure by lowering the number of
target-immobilized beads while increasing the number of wash cy-
cles. After 10 rounds of selection, non-biotinylated PCR products
were puriﬁed and ligated to pGEM-T easy vectors (Promega, Mad-
ison, WI, USA). All DNA sequencing samples were prepared using
the illustra TempliPhi DNA sequencing template ampliﬁcation kits
(GE Healthcare, Piscataway, NJ, USA) and analyzed using an ABI
PRISM 310 Genetic Analyzer (Applied Biosystems, Foster City, CA,
USA).2.3. Surface plasmon resonance (SPR) assay
All SPR analyses were performed using the ProteON XPR360
instrument (Bio-Rad, Hercules, CA, USA) at 25 C. Each aptamer
clone was attached to a poly(A24) tail at the 30 end for immobiliza-
tion onto the NLC sensor chip via a 50-biotinylated oligo (dT20). HA
proteins were injected as an analyte with SB. The dissociation con-
stant was calculated according to the manufacturer’s instructions.2.4. Enzyme-linked aptamer assay (ELAA)
2.4.1. Direct ELAA
The recombinant HA proteins or semi-puriﬁed inﬂuenza viruses
described above were diluted in carbonate buffer for immobiliza-
tion onto wells (Maxisorp F96, Thermo Scientiﬁc/Nunc, Waltham,
MA, USA), with viral protein concentrations ranging from 100 ng
to 100 lg. Wells were coated overnight at 4 C, washed once with
SB, and then blocked with Protein-Free (TBS) blocking buffer
(Thermo Scientiﬁc/Pierce Biotechnology) for 1 h at room tempera-
ture. The 30-biotinylated aptamers were diluted in SB to a ﬁnal
concentration at 1 lM and then denatured at 95 C for 5 min. The
aptamers were added to the virus-coated wells and incubated for
1 h at room temperature. After three washes with SB, streptavi-
din-horseradish peroxidase (SA-HRP) (GE Healthcare) was added,
and the mixture was incubated at room temperature for 30 min
to detect the biotinylated aptamers captured by the immobilized
HA proteins or virus. After three washes with SB, TMB solution
(Moss Inc., Pasadena, MD, USA) was added for detection, and the
solution was incubated for 10 min at room temperature. The reac-
tion was stopped by adding 0.5 N sulfuric acid, and the absorbance
at 450 nm of each well was measured.2.4.2. Sandwich ELAA
Amino groups were conjugated through a C12 linker at the 30
terminus of each aptamer; these modiﬁed aptamers were used
for capture. These aptamers were diluted in carbonate buffer to a
ﬁnal concentration of 0.2 lM and added to each well of an ami-
no-immobilizer plate (Thermo Scientiﬁc/Nunc). The plates were
coated overnight, washed once, and then blocked with 1 M Tris–
HCl, pH 7.4, for 30 min, followed by incubation in Protein-Free
(TBS) blocking buffer for 1 h at room temperature. The wells were
washed three times and HA proteins or semi-puriﬁed inﬂuenza
viruses, diluted in SB, were added to the wells and incubated for
2 h at room temperature. The remaining procedures were the same
as those for described above for direct ELAA.
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3.1. Evaluation and characterization of DNA aptamers by using the SPR
assay
Primers designed for SELEX were optimized in terms of stability
and multiplicity for the DNA library by using the ValFold program
[14]. A nucleotide library was obtained from a pool of 1015 single-
stranded DNA (ssDNA) molecules containing a random 30-mer se-
quence ﬂanked by these designed primers. This random library
was screened with recombinant hemagglutinin (rHA) proteins of
the H5N1 inﬂuenza virus by using the general SELEX procedure
with slight modiﬁcations (see Section 2). Among the 215 clones se-
quenced from the 10 round pools, 15 sequences that were overlap-
ping by more than 5% were observed (data not shown).
To evaluate the binding afﬁnities of these overlapping
sequences, which were considered to be aptamer candidates, SPR
assays were conducted. Among aptamer candidates, three clones,
RHA0006, RHA0385, and RHA1635, were selected based on the
binding strength to rHA. These three RHA aptamers were opti-
mized based on secondary structures calculated using the ValFold
program. The sequences of three optimized aptamers are shown in
Fig. 1, and these aptamers were used in further assays. PredictionFig. 1. Sequence (A) and secondary structure calculated by the Valfold program (B).
ValFold predicts not only canonical Watson–Crick pairs but also G–G pairs derived
from the G-quadruplex by using the stem candidate selection algorithm.
Fig. 2. Binding capacity of RHA aptamers toward rHA was measured using a SPR assay.
poly(dT20)-coated streptavidin sensor chip. RHA0006, RHA0385, and RHA1635 were our
oligonucleotide used in the SELEX procedure. First, 500 nM of the HA1 subunit of H5N
(HA1 + 2, A/Anhui/1/2005) in selection buffer were injected at a ﬂow rate of 50 lL/min. (
Anhui/1/2005, A/California/04/2009, A/Brisbane/59/2007, A/Aichi/2/1968) in selection bu
reported by Cheng et al. Relative units were calculated by resonance units at the end poof secondary structure revealed that RHA0006 and RHA0385
formed a typical G-quadruplex structure, while RHA1635 did not
form this structure (Fig. 1B) [14]. Additionally, potassium ions
were required for efﬁcient binding of both RHA0006 and
RHA0385 to rHA, while RHA1635 did not require potassium ions
for target binding (Supplemental Fig. 1A). These results suggest
that the estimated secondary structures are reliable.
As shown in Fig. 2A, the three aptamers bound to not only the
extracellular domain of rHA (HA1 + 2) but also the subunit 1 of
rHA (HA1) of the same H5N1 virus (A/Anhui/1/2005). The signal
intensity of HA1 + 2 was nearly twice that of HA1. The dissociation
constant (KD) of RHA0006 was calculated to be 1.53  108 M
(rHA1, A/Anhui/1/2005) and 2.47  108 M (rHA1 + 2, A/Anhui/1/
2005), respectively. Since these KD values were similar, the differ-
ence in signal intensity may reﬂect the molecular weight of
HA1 + 2 (approximately 70 kD) and HA1 (approximately 40 kD).
The binding site of the aptamer was thought to a region of HA1.
Next, to evaluate the binding speciﬁcity of the aptamer, rHAs of
various subtypes of inﬂuenza A viruses were used as analytes. As
shown in Fig. 2B, our three aptamers strongly bound to rHA of
not only AIV but also of the seasonal strain (H1N1, H3N2) and pan-
demic strain (H1N1pdm). The three aptamers showed a similar
rank order of binding afﬁnity for each rHA1. Since they did not rec-
ognize His-MIF, which was used as a negative control, the apta-
mers did recognize not the His-tag but were speciﬁc to the HA1
region. Although amino acid homologies of HA1 domain between
AIV and other subtypes are 36–52%, the HA1 domain contains
many conserved region among the strains examined. Thus, broad
speciﬁcity of RHA aptamers is feasible. A22 has previously been re-
ported to be capable of binding to HA1 of the H3 and H2 subtypes
of the inﬂuenza A virus [11]. A10 has also been reported to bind to
HA1 of H5N1, which is the strain used in our binding assay [9]. Un-
der our experimental conditions, both A10 and A22 reacted with
these HA proteins compared to negative control aptamers, but both
binding afﬁnities were signiﬁcantly lower than those of our RHA
aptamers.
3.2. Evaluation and characterization of DNA aptamers by ELAA
To evaluate the binding properties of the aptamers using color-
imetric methods, we conducted an ELAA. First, rHA proteins were(A) SPR assay was performed with 30-poly(A24)-tailed aptamers immobilized onto a
newly identiﬁed HA aptamers, whereas N30 indicates the initial unselected random
1(A/Anhui/1/2005) or the full-length extracellular domain of HA proteins of H5N1
B) Here, 500 nM of HA1 subunit of H5, H1, and H3 subtypes of inﬂuenza A virus (A/
ffer were injected as analytes. A22 has been reported by Joen et al., and A10 has been
int (120 s) of analyte injection, normalized to the amount of immobilized aptamer.
Fig. 3. Binding capacities of RHA aptamers as well as of control ssDNA toward the HA1 subunit of the H5N1 subtype (A/Anhui/1/2005) and H1N1 pandemic strain (A/
California/04/2009) were evaluated by ELAA assays. (A) Direct ELAA. The amount of biotinylated aptamer captured by immobilized HA1 proteins was determined from the
absorbance at 450 nm. (B) Development of effective sandwich-ELAA requiring only our RHA aptamer sequences for detecting the HA1 subunit. Here, 100 nM of 30-aminated
aptamers (–30NH2) was immobilized to the wells and used for capture. After two sequential blocking processes, 1 lg of recombinant HA1 proteins (A/California/04/2009) in
selection buffer was added to the aptamer-coated wells, and then 1 lM of 30-biotinylated aptamers (–30biotin) was reacted. The amount of biotinylated aptamer bound to
HA1 proteins captured by aminated aptamers was determined from the absorbance at 450 nm. The experiment was repeated three times with each data point measured in
duplicate; representative data are shown.
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mers. As shown in Fig. 3A, our aptamers showed signiﬁcant bind-
ing to rHA1 of both H5 and H1 pandemic strains compared with
the control aptamer. Our aptamers showed greater afﬁnity than
both A10 and A22. The detection limit of HA proteins in ELAA using
rHA aptamers was 0.1 lg/well (data not shown). These results sug-
gested that our three aptamers can be used to detect plate-immo-
bilized rHA with high afﬁnity.
Several sandwich systems for thrombin detection employing
aptamers have been recently reported [15,16]. We conﬁrmed that
our newly identiﬁed aptamers were capable of binding to rHA1
with broad speciﬁcities, not only in solution (Fig. 3A) but also in
the solid phase (Fig. 2); therefore, we attempted to develop a novel
sandwich ELAA for hemagglutinin detection. Amino groups were
attached through a C12 linker at the 30 terminus of each aptamer
and were used as capture. rHA1 captured by plate-immobilized
aptamer was detected using a biotinylated-detection aptamer. As
shown in Fig. 3B, the sandwich procedure, which involved
RHA0006 and RHA0385, successfully detected rHA1 with low back-
ground signal. Because aptamers are evoloved in solution, any
modiﬁcation altering the chemical identity of the aptamer can af-
fect its folding and consequently its target binding. Fortunately,
both RHA0006 and RHA0385 effectively functioned as both captureFig. 4. Binding capacities of RHA0006 and RHA0385 toward various subtypes of inﬂuenz
supernatant (1, 10, and 100 lg/well of H5N1 virus, and 0.01, 0.1, and 1 lg/well of other v
was used as the non-inﬂuenza A virus control. (B) Sandwich-ELAA effectively detected t
30NH2) was immobilized onto the wells and used for capture. Different concentrations o
well of other viruses) in selection buffer were added to the aptamer-coated wells, an
remaining procedure for ELAA was the same as that described in Fig. 3. The experim
representative data are shown.aptamers and detection aptamers, although the capturing capacity
of RHA0385 was slightly lower than that of RHA0006. This novel
sandwich-ELAA also detected rHA1 of the H5 strain, while
RHA1635, which did not form the typical G-quadruplex structure,
was difﬁcult to capture and detect, possibly due to modiﬁcations or
a lower sensitivity compared with other RHA aptamers (data not
shown). Surprisingly, regarding both RHA0006 and RHA0385, only
a single aptamer sequence was sufﬁcient for developing sandwich
detection. In this regard, we have speculated that rHA may have
more than one binding site (e.g., carbohydrate chain) for these
aptamers.
3.3. Characteristics of the binding of RHA aptamers to inﬂuenza A
viruses
Because we succeeded in detecting rHAs using the ELAA, which
was composed of RHA aptamers, we next evaluated the binding
afﬁnity and speciﬁcity of both RHA0006 and RHA1635 toward
UV-irradiated inﬂuenza A virus by ELAA. First, direct ELAA was
performed. Serial dilutions of the semipuriﬁed inﬂuenza virus were
directly immobilized onto each well of a 96-well plate with
carbonate buffer. Because AIV (A/Japanese White Eye/Hong Kong/
1038/06) was grown in speciﬁc pathogen-free fertile eggs anda A virus were measured by ELAA. (A) Ten-fold serial dilutions of semipuriﬁed virus
iruses) were immobilized on 96-well plates with carbonate buffer. The Sindbis virus
he various subtypes of inﬂuenza A virus. Here, 100 nM of 30-aminated aptamers (–
f semipuriﬁed virus supernatant (1 and 10 lg/well of H5N1 virus and 0.1 and 1 lg/
d then 1 lM of 30-biotinylated RHA0006 aptamers (–30biotin) were reacted. The
ent was repeated three times with each data point measured in duplicate, and
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derived from fertile eggs, AIV was used at a 100-fold concentration,
as determined from the preliminary estimation shown in Supple-
mental Fig. 1B. As shown in Fig. 4A, both RHA0006 and RHA1635
showed signiﬁcant binding to all subtypes of inﬂuenza A viruses
in a dose-dependent manner. A signiﬁcant difference was observed
between the binding capacity of the pandemic strains (A/Califor-
nia/04/09) and other inﬂuenza A virus strains for both RHA0006
and RHA0385. This tendency comparably improved when evalu-
ated by sandwich ELAA (Fig. 4B), and the binding signal of RHA
aptamers toward rHA1 of the same pandemic strains was
equivalent to those of other seasonal strains (Fig. 2B); this is likely
because physical adsorption of pandemic strains negatively
affected the interaction between the aptamer and the pandemic
strain, although the mechanism was unclear.
Finally, we examined whether our novel sandwich-ELAA could
detect the inﬂuenza A virus. As shown in Fig. 3B, both RHA0385
and RHA0006 could detect the inﬂuenza A virus, speciﬁcally in a
dose-dependent manner. Importantly, the binding afﬁnities of both
RHA aptamers toward AIV were 10-fold higher than those mea-
sured by direct ELAA, as shown in Fig. 4A. In direct ELAA, the AIV
sample required 100-fold higher concentration than that of other
inﬂuenza A viruses to generate an equivalent binding signal, and
this tendency was reproducible. Since the AIV sample was not
puriﬁed from fertile eggs, AIV itself could be immobilized more
efﬁciently because the capture aptamer puriﬁed AIV in the pres-
ence of a high concentration of contaminants.
We succeeded in generating DNA aptamers that target HA pro-
teins of the inﬂuenza A virus with high afﬁnity and broad subtype
speciﬁcity. Furthermore, we developed a selective, sensitive sand-
wich-ELAA employing only RHA aptamer sequences for detecting
the inﬂuenza A virus. Infection experiments, including a hemagglu-
tination inhibition test (data not shown), indicated that the RHA
aptamers did not show antiviral activity. However, the binding
afﬁnities of RHA aptamers were remarkably higher than those of
A22 or A10 (Figs. 2 and 3). Since our RHA aptamers showed signif-
icant and speciﬁc binding to broad subtypes of inﬂuenza A viruses,
we will evaluate the binding properties against the H7N9 subtype,
which has recently been found to cause human infections in China
[17].
Because of the speciﬁcity and low detection limits, double-anti-
body sandwich detection is commonly used in clinical diagnostics,
including chromatography or colorimetric enzymatic assays. In
addition, besides thrombin detection described above, consecutive
reports in 2013 regarding aptamer-based sandwich systems for
whole viruses [18], antibodies [19], and small molecules [20] have
suggested the feasibility of using aptamers as diagnostic tools.
Although the sandwich ELAA described here will need to be further
characterized to determine the limit of detection and subtype
speciﬁcity as a simple and sensitive inﬂuenza A virus diagnostic
tool, our novel aptamer assay will be one candidate applicable to
a rapid and cost effective diagnostic, requiring broad subtype
speciﬁcities.
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